AMADUCCI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 3.583
EU - Europa 1.535
AS - Asia 441
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 5.578
Nazione #
US - Stati Uniti d'America 3.567
SE - Svezia 353
IE - Irlanda 301
IT - Italia 224
UA - Ucraina 216
CN - Cina 147
HK - Hong Kong 133
RU - Federazione Russa 133
DE - Germania 121
FI - Finlandia 86
SG - Singapore 68
GB - Regno Unito 62
KR - Corea 48
TR - Turchia 32
FR - Francia 19
CA - Canada 16
SC - Seychelles 13
JO - Giordania 9
GR - Grecia 6
NL - Olanda 4
BE - Belgio 3
EU - Europa 2
IN - India 2
NZ - Nuova Zelanda 2
PL - Polonia 2
VN - Vietnam 2
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
MA - Marocco 1
RO - Romania 1
Totale 5.578
Città #
Fairfield 474
Chandler 393
Jacksonville 342
Dublin 301
Woodbridge 235
Ashburn 222
Cambridge 221
Seattle 201
Wilmington 190
Houston 158
Ann Arbor 101
Princeton 91
Dearborn 85
Boardman 76
Altamura 74
Lawrence 68
Medford 57
Hong Kong 55
Boston 54
Beijing 53
Singapore 34
Buffalo 33
Izmir 30
Florence 25
San Diego 23
Los Angeles 20
Shanghai 20
Kent 18
Washington 18
Norwalk 17
Hefei 14
Seoul 13
New York 12
Auburn Hills 11
Andover 10
Bremen 9
Hillsboro 8
Kunming 8
Toronto 8
Milan 7
Rome 7
Nanjing 6
Verona 6
Guangzhou 5
Rockland 5
Athens 4
Frankfurt Am Main 4
Jinan 4
London 4
Nanchang 4
Redmond 4
West Jordan 4
Arezzo 3
Brussels 3
Fuzhou 3
Old Bridge 3
Salerno 3
Taiyuan 3
Thiene 3
Xian 3
Ancona 2
Bergamo 2
Bologna 2
Hanoi 2
Mogliano Veneto 2
Pisa 2
Serra 2
Sesto Fiorentino 2
Trento 2
Venice 2
Auckland 1
Baotou 1
Brno 1
Cardiff 1
Charlottetown 1
Chiswick 1
Christchurch 1
Falls Church 1
Figline Valdarno 1
Grevenbroich 1
Hangzhou 1
Hebei 1
Helsinki 1
Hounslow 1
Imola 1
Islington 1
Istanbul 1
Jiaxing 1
Kamloops 1
Kilburn 1
Kissimmee 1
Lanzhou 1
Laurel 1
Lausanne 1
Leawood 1
Mogilëv 1
Naaldwijk 1
Napoli 1
Oakland 1
Padova 1
Totale 3.920
Nome #
Acylphosphatase levels in Alzheimer's disease cultured skin fibroblasts 128
Use of phosphatidylserine in Alzheimer's disease. 116
Abnormalities of mitochondrial enzymes in hereditary ataxias. 106
The World Health Organization cross-national research program on age-associated dementias. 103
Lack of efficacy of phosphatidylcholine in ataxias. 101
Acute subcortical lesions modify cortical muscarinic receptors in human brain 100
Growth properties and growth factor responsiveness in skin fibroblasts from centenarians. 99
Lipoderivatives of an immunodominant epitope of myelin basic protein increased T cell responsiveness in Lewis rats. 98
No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. 97
Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. 94
CEREBRAL SOLUBLE UBIQUITIN IS INCREASED IN PATIENTS WITH ALZHEIMER'S DISEASE 94
Alzheimer skin fibroblasts show increased susceptibility to free radicals. 92
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigrees. 92
Electronystagmography in the diagnosis of multiple sclerosis. 88
Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis 87
Free radical injury in skin cultured fibroblasts from Alzheimer's disease patients. 87
Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease. 86
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid bound form. 86
Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. 85
The first Alzheimer disease case: a metachromatic leukodystrophy? 84
Lactate production and glycolytic enzymes in sporadic and familial Alzheimer’s disease. 82
Stimulation of glycolytic key enzymes in cerebral cortex by insulin. 81
Long-term safety of azathioprine therapy in multiple sclerosis. 81
APP717 and Alzheimer's disease in Italy 76
Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens. 76
Absence of APP717 mutation in Italian FAD families 75
Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia 74
Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients 74
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging. 73
Analysis of apolipoprotein E, alpha1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man. 72
Energy metabolism in demented brain. 71
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene 71
Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate 71
Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease. 68
PET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation 68
Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. 66
Chemical lateralization in human temporal cortex. 66
Molecular genetic strategies in familial Alzheimer's disease. Theoretical and practical considerations. 65
Analysis of the c-FOS gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial alzheimer's disease 65
Use of phosphatidylserine in sporadic and familial Alzheimer's disease 65
Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease. 64
Normal lactate production and altered hexokinase activity in fibroblasts and leukocytes from familial Alzheimer's disease patients 64
Glutathione levels in lymphoblasts from patients with familial Alzheimer's disease linked to presenilin genes 63
The genetic defect causing familial Alzheimer's disease maps on chromosome 21 62
Biochemical differences between the left and right hemispheres. Preliminary observations on choline acetyl transferase (CAT) activity. 62
Linkage Analysis in familial Alzheimer's disease 62
Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine 60
Linkage Analysis in Italian Pedigrees with Autosomal Dominant Familial Alzheimer’s DiseaseCerebral Ischemia and Dementia 58
Sex-related differences in human cerebral hemodynamics. 58
Residual disability and early hemodynamic assessment in acute cerebral ischemia 58
Research on Alzheimer disease in Italy: present and prospects. 56
Autonomic function evaluation in "de novo" Parkinson disease 56
Malattie neurolo¬giche. In: Trattato di Medicina Interna di Teodori U e Gentilini I, vol. III. 55
Cerebral mean flow velocity in patients with conversion symptoms 55
Impaired cerebral autoregulation in patients with shy-drager syndrome 54
Enzymes of energy metabolism in demented brain 53
Differences by age and sex between temporal and occipital inadequate acoustic windows 52
Epidemiologia delle malattie del sistema nervoso in Italia. In: Il decennio del cervello 17-23. 51
Is dementia primarily a subcortical disease? Appraisal of recent biochemical observations. 51
La patologia neurologica. In: La salute degli Italiani. Rapporto 1991. 47
Activity of pyruvate de¬hydrogenase complex, glutamate dehydrogenase, lactete dehydrogenase, and choline acetyl¬transferase in rats after intracerebroventricular administration of bromopyruvate or AF64A 47
Technical limits in transcranial Doppler recording: inadequate acoustic windows. 46
Immunosuppression in multiple sclerosis: state of the art and future perspectives. In: A multidisciplinary approach to myelin diseases II 46
Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program. 45
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging. 44
La sclerosi multipla malattia degli anticorpi senza senso. 42
Vasculopatie Cerebrali (Parte I) 42
Familial Alzheimer's disease fibroblasts with presenilin gene mutations: Alteration of acylphosphatase levels 41
Absence of association between intronic polymorphism in PS-1 gene and alzheimer's disease in italian patients 41
Short-term intensive cyclophosphamide treatment in progressive MS 41
Early predictors of lesion extension in acute ischemic stroke 41
Gli esami di laboratorio delle demenze. 39
Lateralizzazione neurochimica nell'encefalo umano. 39
Effectiveness of azathioprine treatment in MS 38
Atassie Olivopontocerebellari: Biochimica 34
Linkage analysis of early onset familial form of Alzheimer's disease (FAD) in pedigree of italian origin 34
Vasculopatie Cerebrali (Parte II) 33
Rhein and derivates. In vitro studies on their capacity to inhibit certain proteases. 33
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. 32
Neuroanatomical and neurochemical correlates of cerebral dominance: A minireview 32
COLLECTION OF NERVOUS TISSUE FOR BRAIN BANTS: ETHICAL AND LEGAL ISSUE 32
Clinical pathology of recessive and dominant olivopontocerebellar atrophy. Observation on glutamate dehydrogenase activity. 32
Energy metabolism in aging and dementia 30
Lateralization of Cholinergic and Energy Metabolism Related Enzymes in Human Temporal CortexDynamics of Cholinergic Function 30
Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. 30
Aging of the brain and dementia: Biological markers in non neuronal tissues 28
Erratum: Cerebral soluble ubiquitin is increased in patients with Alzheimer's disease (Neurosci. Lett. 151 (1993) (158-161)) 27
Lateralization of cholinergic and energy related ezymes in human temporal cortex 26
Familial and sporadic Alzheimer's disease: Molecular Genetic Approaches. 24
Variations of brain pyruvate dehydrogenase complex (PDHc) activity after inhibition with bromopyruvate in rats-a model of dementia? 21
Molecular genetics of autosomal dominant familial Alzheimer's disease 20
Totale 5.594
Categoria #
all - tutte 16.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.136 0 89 20 109 100 197 178 166 103 58 93 23
2020/2021775 64 37 139 56 9 110 6 77 57 104 45 71
2021/2022524 16 70 29 20 24 12 22 22 22 13 104 170
2022/20231.457 153 232 44 162 139 266 170 92 152 0 38 9
2023/2024452 25 65 92 29 39 41 26 74 1 15 33 12
2024/2025190 108 82 0 0 0 0 0 0 0 0 0 0
Totale 5.594